Evidence map›Paper›PMID 38435506›Full record

ArticleClinical case reports2024

An atorvastatin-induced positive anti-HMGCR immune-mediated necrotizing myopathy case.

Nattanicha Chaisrimaneepan, Jerapas Thongpiya, Pitchaporn Yingchoncharoen, Sakditad Saowapa

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nattanicha ChaisrimaneepanDepartment of Internal Medicine Texas Tech University Health Sciences Center Lubbock Texas USA.ORCID https://orcid.org/0000-0002-3183-7853
Jerapas ThongpiyaDepartment of Internal Medicine Texas Tech University Health Sciences Center Lubbock Texas USA.
Pitchaporn YingchoncharoenDepartment of Internal Medicine Texas Tech University Health Sciences Center Lubbock Texas USA.ORCID https://orcid.org/0000-0003-0764-6472
Sakditad SaowapaDepartment of Internal Medicine Texas Tech University Health Sciences Center Lubbock Texas USA.
Texas Tech University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Statins can commonly cause myopathy. Most of the time, stopping the culprit drug should solve the problem. However, if the drug has been discontinued but muscle weakness continues to worsen, immune-mediated myopathy should be taken into consideration.

Indexed as

anti‐HMGCRatorvastatinautoimmuneinflammatory myositisstatin

Identifiers

PMID38435506
PMCPMC10901786
OpenAlexW4392290986

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.